Literature DB >> 30656806

Pharmacist-led influenza vaccination services in residential aged care homes: A pilot study.

Nicole C McDerby1, Sam Kosari1, Kasia S Bail2, Alison J Shield1, Tamra MacLeod3, Gregory M Peterson1,4, Mark Naunton1.   

Abstract

OBJECTIVES: The feasibility of pharmacist-led influenza vaccination services in residential aged care homes has not previously been studied. The primary objective of this pilot study was to evaluate the feasibility of this service. The secondary objective was to assess the effect of the service on employee vaccination rates.
METHODS: An in-house pharmacist-led vaccination service was implemented at a single site in 2017. De-identified employee influenza vaccination records at this site for 2016 and 2017 were compared to assess the change in vaccination rate.
RESULTS: The residential care pharmacist administered 37% of all influenza vaccinations to employees (n = 78) in 2017. Between 2016 and 2017, there was a significant improvement in the employee vaccination rate at the site (46.5% vs 69.2%, P < 0.01).
CONCLUSIONS: It is feasible for pharmacists to administer influenza vaccinations to employees in residential aged care. The flexibility of an in-house pharmacist improves accessibility and can therefore promote uptake of influenza vaccination by employees.
© 2019 AJA Inc.

Keywords:  aged care; employees; influenza; nursing homes; pharmacists; preventive programs; vaccination

Year:  2019        PMID: 30656806     DOI: 10.1111/ajag.12611

Source DB:  PubMed          Journal:  Australas J Ageing        ISSN: 1440-6381            Impact factor:   2.111


  2 in total

1.  Safety survey by clinical pharmacists on COVID-19 vaccination from a single center in China.

Authors:  Guangfei Wang; Lin Zhu; Yiqing Zhu; Qiaofeng Ye; Xin Yu; Meng Fu; Jinmiao Lu; Xiaoxia Li; Yidie Huang; Junqi Zhang; Jianger Lan; Ziwei Li; Xiaowen Zhai; Hong Xu; Zhiping Li
Journal:  Hum Vaccin Immunother       Date:  2021-04-22       Impact factor: 3.452

2.  Integrating pharmacists into aged care facilities to improve the quality use of medicine (PiRACF Study): protocol for a cluster randomised controlled trial.

Authors:  Sam Kosari; Jane Koerner; Mark Naunton; Gregory M Peterson; Ibrahim Haider; Emily Lancsar; David Wright; Theo Niyonsenga; Rachel Davey
Journal:  Trials       Date:  2021-06-11       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.